Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Co-transplantation of Mesenchymal Stem Cells and HLA-mismatched Allogeneic Hematopoietic Cells After Nonmyeloablative Conditioning: a Phase II Randomized Double-blind Study

NCT01045382 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT01045382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01045382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Co-transplantation of Mesenchymal Stem Cells and HLA-mismatched Allogeneic Hematopoietic Cells After Nonmyeloablative Conditioning: a Phase II Randomized Double-blind Study
Lead sponsor
University of Liege
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2010
Completion date
August 31, 2021
Enrollment
39 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's disease, leukemia, lymphoblastic, acute, leukemia, lymphocytic, chronic, leukemia, myelocytic, chronic, leukemia, myeloid, acute, lymphoma, non-hodgkin, multiple myeloma, myelodysplastic syndromes, myeloproliferative disorders